We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
-7.28%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$6.53B
AUM Growth
-$382M
Cap. Flow
+$195M
Cap. Flow %
2.99%
Top 10 Hldgs %
59.37%
Holding
305
New
83
Increased
54
Reduced
76
Closed
50

Top Buys

Rank Stock Value
1
PTCT icon
PTC Therapeutics
PTCT
+$108M
2
BUD icon
AB InBev
BUD
+$39.8M
3
IRWD icon
Ironwood Pharmaceuticals
IRWD
+$33.9M
4
CRL icon
Charles River Laboratories
CRL
+$32M
5
CL icon
Colgate-Palmolive
CL
+$27M

Top Sells

Rank Stock Value
1
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$93.3M
2
PFE icon
Pfizer
PFE
+$76.9M
3
JNJ icon
Johnson & Johnson
JNJ
+$53.7M
4
INCY icon
Incyte
INCY
+$46.6M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$45.7M

Sector Composition

Rank Sector Weight
1 Healthcare 34.38%
2 Consumer Staples 6.6%
3 Technology 4.23%
4 Consumer Discretionary 3.89%
5 Communication Services 1.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RVPH
126
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
$2.93M 0.04%
30,000
-11,200
-27% -$1.04M
CMRX
127
DELISTED
Chimerix, Inc.
CMRX
$2.76M 0.04%
2,872,000
-304,000
-10% -$331K
SPOT icon
128
Spotify
SPOT
$97.7B
$2.61M 0.04%
+16,873
New +$2.57M
XFOR icon
129
X4 Pharmaceuticals
XFOR
$393M
$2.57M 0.04%
78,533
-20,667
-21% -$901K
ZSQR
130
Z Squared Inc
ZSQR
$208M
$2.57M 0.04%
110,600
-5,950
-5% -$137K
ELDN icon
131
Eledon Pharmaceuticals
ELDN
$267M
$2.5M 0.04%
1,824,000
-18,803
-1% -$25.1K
HOOK
132
DELISTED
HOOKIPA Pharma
HOOK
$2.29M 0.04%
371,200
-14,400
-4% -$106K
HEPA
133
DELISTED
Hepion Pharmaceuticals
HEPA
$1.98M 0.03%
+7,952
New +$2.97M
BFX
134
DELISTED
BowFlex Inc.
BFX
$1.92M 0.03%
2,260,000
-1,030,638
-31% -$1.02M
ARQQ icon
135
Arqit Quantum
ARQQ
$374M
$1.77M 0.03%
+119,200
New +$2.91M
SYBX
136
DELISTED
Synlogic
SYBX
$1.69M 0.03%
+599,874
New +$4.07M
UPH
137
DELISTED
UpHealth, Inc.
UPH
$1.59M 0.02%
1,619,000
+145,000
+10% +$212K
MUSA icon
138
Murphy USA
MUSA
$9.9B
$1.58M 0.02%
+4,619
New +$1.47M
NKE icon
139
Nike
NKE
$62.3B
$1.44M 0.02%
15,015
-32,985
-69% -$3.39M
ELOX
140
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
$1.32M 0.02%
+275,000
New +$1.54M
XLP icon
141
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.9B
$1.24M 0.02%
+18,060
New +$1.32M
ATRC icon
142
AtriCure
ATRC
$2.01B
$1.22M 0.02%
+27,928
New +$1.36M
SIG icon
143
Signet Jewelers
SIG
$3.65B
$1.14M 0.02%
+15,878
New +$1.18M
CELU icon
144
Celularity
CELU
$19.8M
$1.04M 0.02%
470,000
+5,700
+1% +$20.5K
ZIVO
145
DELISTED
Zivo Bioscience, Inc. Common Stock
ZIVO
$1.04M 0.02%
133,645
-37,000
-22% -$412K
GOLF icon
146
Acushnet Holdings
GOLF
$5.5B
$974K 0.01%
+18,362
New +$1.03M
BCTXW
147
DELISTED
BriaCell Therapeutics Corp Warrant
BCTXW
$926K 0.01%
375,000
– –
LEXX icon
148
Lexaria Bioscience
LEXX
$8.82M
$889K 0.01%
+59,285
New +$812K
BBAI icon
149
BigBear.ai
BBAI
$1.44B
$827K 0.01%
548,000
-6,952,000
-93% -$12.1M
M icon
150
Macy's
M
$6.61B
$810K 0.01%
+69,779
New +$978K
4 5
6
7 8

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

Armistice Capital's Q3 2023 Portfolio in Review

As of Q3 2023, Armistice Capital held 305 positions worth $6.53B, down 5.5% from $6.91B the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Armistice Capital's Q3 2023 filing shows 83 new, 54 increased, 76 reduced and 50 closed positions. Its largest new stake was AB InBev: 703,000 shares worth $38.9M. The largest sale was Mirati Therapeutics, Inc. Common Stock, an estimated $93.3M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, down from 39% a quarter earlier, followed by Consumer Staples and Technology.

  • Armistice Capital's largest Q3 2023 buy was AB InBev: 703,000 shares worth $38.9M.
  • Armistice Capital added most to PTC Therapeutics in Q3 2023, an estimated $108M increase.
  • Armistice Capital's biggest Q3 2023 reduction was Mirati Therapeutics, Inc. Common Stock, cutting an estimated $93.3M.
  • Armistice Capital fully exited Pfizer in Q3 2023, selling an estimated $76.9M.
  • Armistice Capital's ten largest holdings make up 59% of its $6.53B portfolio in Q3 2023.
  • Armistice Capital opened 83 new positions and closed 50 in Q3 2023.
  • Armistice Capital's portfolio value fell 5.5% quarter-over-quarter to $6.53B.

Based on Armistice Capital's 13F filing for Q3 2023, filed 14 Nov 2023.